Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2020.0295

Commentary

Modern treatment of colorectal cancer: progress and limitations.

Prof. Andreas Sendler, MD, PhD.

 

Abstract
Substantial progress in the standardization of colorectal cancer (CRC) treatment, including surgical resection, chemotherapy and radiotherapy for rectal tumors, has been translated into improved oncological outcomes of hundreds of thousands of CRC patients.
However, multiple challenges including clinical prognosis of non-resectable tumors and modest efficacy of targeted drugs in this palliative stage of disease and no approval of these agents in resectable patients have not overcome yet. Controversery in treatment guidelines specifically for rectal cancer and future potential solutions are also discussed.

(Citation: Gastric & Breast Cancer 2020; 15(1): 37-42)

Back
You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 15 January 2020